Ronald Frost - 10 Aug 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
10 Aug 2022
Net transactions value
-$921,000
Form type
4
Filing time
12 Aug 2022, 17:41:09 UTC
Previous filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $321,000 +20,000 +132% $16.05* 35,144 10 Aug 2022 Direct
transaction MMSI Common Stock, No Par Value Sale $1,242,000 -20,000 -57% $62.10 15,144 10 Aug 2022 Direct F1
holding MMSI Common Stock, No Par Value 16,284 10 Aug 2022 By 401(k) plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -20,000 -100% $0.000000* 0 10 Aug 2022 Common stock 20,000 $16.05 Direct F2
holding MMSI Non-qualified stock options (right to buy) 9,681 10 Aug 2022 Common Stock 9,681 $56.25 Direct F3
holding MMSI Non-qualified stock options (right to buy) 50,000 10 Aug 2022 Common Stock 50,000 $28.20 Direct F4
holding MMSI Non-qualified stock options (right to buy) 40,000 10 Aug 2022 Common Stock 40,000 $44.80 Direct F5
holding MMSI Non-qualified stock options (right to buy) 30,000 10 Aug 2022 Common Stock 30,000 $55.73 Direct F6
holding MMSI Non-qualified stock options (right to buy) 16,722 10 Aug 2022 Common Stock 16,722 $37.71 Direct F7
holding MMSI Non-qualified stock options (right to buy) 8,094 10 Aug 2022 Common Stock 8,094 $65.03 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ronald Frost is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.05 to $62.24, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Become exercisable in equal annual installments of 20% commencing 01/28/2017.
F3 Become exercisable in equal annual installments of 25% commencing 03/19/2022.
F4 Become exercisable in equal annual installments of 20% commencing 04/14/2018.
F5 Become exercisable in equal annual installments of 20% commencing 03/02/2019.
F6 Become exercisable in equal annual installments of 20% commencing 03/01/2020.
F7 Become exercisable in equal annual installments of 25% commencing 02/26/2021.
F8 Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.